We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Takes Aim At Watson Over Lotrel

Law360 (March 16, 2006, 12:00 AM EST) -- Swiss pharmaceutical company Novartis Corp. is suing generic drug maker Watson Pharmaceuticals on charges of infringement concerning Novartis’ hypertension treatment Lotrel.

The suit, filed earlier this week in the U.S. District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.